Showing results (481-490 of 867) with videos related to
Sort By:
Pageof 87
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 2, 2013
The Multiple Sclerosis Intimacy and Sexuality Questionnaire -- re-validation and development of a 15-item version with a large US sampleFrederick W Foley, Vance Zemon, Denise Campagnolo, et al.Statistics in Medicine|May 10, 2024
Novel non-linear models for clinical trial analysis with longitudinal data: A tutorial using SAS for both frequentist and Bayesian methodsGuoqiao Wang, Whedy Wang, Brian Mangal, et al.Pediatrics|September 30, 2009
Differentiating PFAPA syndrome from monogenic periodic feversMarco Gattorno, Roberta Caorsi, Antonella Meini, et al.Brain Structure & Function|April 30, 2015
Complex motor task associated with non-linear BOLD responses in cerebro-cortical areas and cerebellumAdnan A S Alahmadi, Rebecca S Samson, David Gasston, et al.Journal of Neurology, Neurosurgery, and Psychiatry|November 3, 2012
Isolated theory of mind deficits and risk for frontotemporal dementia: a longitudinal pilot studyMatteo Pardini, Leonardo Emberti Gialloreti, Maria Mascolo, et al.Trials|May 11, 2019
MEsenchymal StEm cells for Multiple Sclerosis (MESEMS): a randomized, double blind, cross-over phase I/II clinical trial with autologous mesenchymal stem cells for the therapy of multiple sclerosisAntonio Uccelli, Alice Laroni, Lou Brundin, et al.Arthritis and Rheumatism|October 31, 2009
The 423Q polymorphism of the X-linked inhibitor of apoptosis gene influences monocyte function and is associated with periodic feverMassimo Ferretti, Marco Gattorno, Annalisa Chiocchetti, et al.Therapeutic Advances in Neurological Disorders|February 20, 2025
CSF IL-6, GDF-15, GFAP and NfL levels in early Alzheimer disease: a pilot studyDomenico Plantone, Matteo Pardini, Carlo Manco, et al.Brain : a Journal of Neurology|April 1, 2015
Magnetization transfer ratio measures in normal-appearing white matter show periventricular gradient abnormalities in multiple sclerosisZheng Liu, Matteo Pardini, Özgür Yaldizli, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|August 11, 2021
Sustained reduction of serum neurofilament light chain over 7 years by alemtuzumab in early relapsing-remitting MSJens Kuhle, Nadia Daizadeh, Pascal Benkert, et al.Pageof 87